BOSTON A Massachusetts doctor pleaded guilty to one count of health care fraud stemming from accusations that he faked research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and Celebrex. Dr. Scott Reuben, an anesthesiologist, also agreed to repay $361,932 of research grants and forfeit assets worth at least $50,000 as penalty for
Update 2: Merck 1Q Profit Slips As Sales Suffer
Merck & Co. said Thursday that its first-quarter profit slipped 15 percent as sales continued to suffer from the drugmaker's decision to pull its popular Vioxx painkiller from the market because of safety concerns. estimate of $5.28 billion. Excluding Vioxx sales in the 2004 quarter, total
Vioxx Could Rejoin Painkillers on Market
The popular painkillers Celebrex and Bextra are likely to stay on the market, and Vioxx may rejoin them, now that government advisers have concluded their benefits outweigh their risks.
Judge selects Alabama lawyer for federal Vioxx suits
NEW YORK - The federal Vioxx cases took a major step forward on Friday when U.S Merck & Co. took Vioxx off the market last year after it was linked
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved